Preparative therapies used for those with Fanconi's anemia undergoing stem cell transplants and subsequent engraftment rates.
Fanconi anemia patients are often treated with stem cell transplants to prevent myelodysplastic changes or leukemic progression. A variety of preparative regimens have been utilized. A case of a 13-year-old child with Fanconi's anemia is presented to highlight the preparative therapy utilized, engraftment rates which have been seen and the incidence of graft-vs.-host disease (GvHD). A review of the literature suggests the most successful preparative therapies with the highest engraftment rates and also suggests the best GvHD regimens.
Trigg
Michael E
ME
Department of Pediatrics, Division of Blood and Bone Marrow Transplantation, A. I. duPont Hospital for Children, Wilmington, DE 19803, USA.
Bond
Robert
R
D000293:Adolescent; D005199:Fanconi Anemia / Q000628:therapy*; D006801:Humans; D008297:Male; D033581:Stem Cell Transplantation / Q000009:adverse effects / Q000379:methods*; D019172:Transplantation Conditioning / Q000009:adverse effects / Q000379:methods*